Moneycontrol
Mar 21, 2017 10:28 PM IST | Source: CNBC-TV18

FDA Woes: Pharma Companies feel the US FDA heat

The US drug regulator off late, has been a cause of headaches for many domestic pharmaceutical companies. Today, shares of Divis Laboratories tanked 20 percent after an import alert was issued its on Vizag unit. The Dr Reddy's Laboratories shares also hit a 52-week low after the company's Duvvada plant received 13 observations which included repeats from a November, 2015 warning letter.

The US drug regulator off late, has been a cause of headaches for many domestic pharmaceutical companies. On March 21, the shares of Divis Laboratories tanked 20 percent after an import alert was issued on its Vizag unit.  The Dr Reddys Laboratories shares also hit a 52-week low after the company's Duvvada plant received 13 observations which included repeats from a November, 2015 warning letter.

Kalpesh Kumar Vaghela of Infra Control Systems, Dr Gurudatta of Estima Pharma and Brian Tempest the Former Ranbaxy Chief discussed the concerns faced by pharmaceutical companies.

Watch accompanying videos for more...

Sections
Follow us on
Available On